Indivior Pharmaceuticals Inc
INDV
Peringkat dalam Saham
#3818
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Harga Saham
$34.63
Kapitalisasi Pasar
$4.32B
Perubahan (1 hari)
2.25%
Perubahan (1 tahun)
42.58%
Negara
US
Perdagangan Indivior Pharmaceuticals Inc (INDV)
Kategori
Healthcare
Laba untuk Indivior Pharmaceuticals Inc (INDV)
Laba pada Jun 2026 TTM: $393.00M
Menurut laporan keuangan terbaru dari Indivior Pharmaceuticals Inc, laba saat ini perusahaan adalah $393.00M. Pada tahun 2023, perusahaan memperoleh laba sebesar $-149.00M, penurunan dibandingkan dengan laba tahun 2022 sebesar $-89.00M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Indivior Pharmaceuticals Inc dari 2016 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $393.00M | 2,707.14% |
| 2024 | $14.00M | -109.40% |
| 2023 | $-149.00M | 67.42% |
| 2022 | $-89.00M | -146.84% |
| 2021 | $190.00M | -209.83% |
| 2020 | $-173.00M | -196.11% |
| 2019 | $180.00M | -32.21% |
| 2018 | $265.53M | 84.52% |
| 2017 | $143.91M | 60.35% |
| 2016 | $89.75M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 349.00% |
IN
|
